IHR.L
Impact Healthcare REIT PLC [IHR.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
IHR.L Stock Summary
Top 10 Correlated ETFs
IHR.L
Top 10 Correlated Stocks
IHR.L
In the News
IHR.L Financial details
Company Rating
Buy
Market Cap
348.9M
Income
65.72M
Revenue
93.48M
Book val./share
1.15
Cash/share
0.02
Dividend
0.03
Dividend %
0.04%
Employees
-
Optionable
No
Shortable
Yes
Earnings
19 Mar 2024
P/E
20.83
Forward P/E
690.83
PEG
0.74
P/S
17.7
P/B
0.79
P/C
4145
P/FCF
12.67
Quick Ratio
16.77
Current Ratio
16.77
Debt / Equity
0.38
LT Debt / Equity
0.38
-
-
EPS (TTM)
0.16
EPS next Y
0.12
EPS next Q
-
EPS this Y
177.14%
EPS next Y
-29.92%
EPS next 5Y
-48.42%
EPS last 5Y
3.71%
Revenue last 5Y
15.83%
Revenue Q/Q
15.17%
EPS Q/Q
-22.97%
-
-
-
-
SMA20
2.44%
SMA50
-2.33%
SMA100
-2.33%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
4%
ROC
0.04%
Gross Margin
100%
Oper. Margin
99%
Profit Margin
80%
Payout
152%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
77.1-112.688
52W High
-25.98%
52W Low
+7.66%
RSI
49
Rel Volume
0.86
Avg Volume
633.67K
Volume
545.19K
Perf Week
-1.31%
Perf Month
2.09%
Perf Quarter
4.94%
Perf Half Y
2.6%
-
-
-
-
Beta
0.335
-
-
Volatility
0.81%, 1.3%
Prev Close
-0.84%
Price
82.9
Change
-3.04%
IHR.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.1 | 0.1 | 0.11 | 0.11 | 0.12 | |
| Net income per share | 0.1 | 0.09 | 0.09 | 0.04 | 0.12 | |
| Operating cash flow per share | 0.05 | 0.06 | 0.06 | 0.08 | 0.07 | |
| Free cash flow per share | 0.05 | 0.35 | 0.06 | 0.05 | 0.06 | |
| Cash per share | 0.19 | 0.02 | 0.04 | 0.06 | 0.02 | |
| Book value per share | 1.34 | 1.09 | 1.16 | 1.14 | 1.15 | |
| Tangible book value per share | 1.34 | 1.09 | 1.16 | 1.14 | 1.15 | |
| Share holders equity per share | 1.34 | 1.09 | 1.16 | 1.14 | 1.15 | |
| Interest debt per share | 0.11 | 0.25 | 0.35 | 0.37 | 0.46 | |
| Market cap | 274.27M | 347.66M | 406.3M | 409.56M | 369.43M | |
| Enterprise value | 249.94M | 413.9M | 503.94M | 524.23M | 539.98M | |
| P/E ratio | 10.42 | 12.08 | 12.71 | 24.25 | 7.57 | |
| Price to sales ratio | 11.32 | 11.15 | 11.01 | 9.54 | 7.31 | |
| POCF ratio | 19.58 | 17.55 | 18.71 | 13.89 | 13.16 | |
| PFCF ratio | 19.58 | 3.11 | 19.66 | 22.4 | 14.96 | |
| P/B Ratio | 0.81 | 0.99 | 1.03 | 0.92 | 0.77 | |
| PTB ratio | 0.81 | 0.99 | 1.03 | 0.92 | 0.77 | |
| EV to sales | 10.31 | 13.27 | 13.66 | 12.21 | 10.69 | |
| Enterprise value over EBITDA | 13.03 | 16.25 | 16.4 | 15.51 | 12.91 | |
| EV to operating cash flow | 17.84 | 20.89 | 23.2 | 17.78 | 19.24 | |
| EV to free cash flow | 17.84 | 3.71 | 24.38 | 28.67 | 21.87 | |
| Earnings yield | 0.1 | 0.08 | 0.08 | 0.04 | 0.13 | |
| Free cash flow yield | 0.05 | 0.32 | 0.05 | 0.04 | 0.07 | |
| Debt to equity | 0.07 | 0.22 | 0.29 | 0.31 | 0.38 | |
| Debt to assets | 0.07 | 0.18 | 0.22 | 0.23 | 0.27 | |
| Net debt to EBITDA | -1.27 | 2.6 | 3.18 | 3.39 | 4.08 | |
| Current ratio | 15.67 | 2.58 | 2.21 | 1.01 | 0 | |
| Interest coverage | 10.34 | 10.31 | 9.17 | 5.84 | 4.36 | |
| Income quality | 0.53 | 0.69 | 0.68 | 1.75 | 0.57 | |
| Dividend Yield | 0.06 | 0.06 | 0.05 | 0.06 | 0.08 | |
| Payout ratio | 0.61 | 0.69 | 0.68 | 1.52 | 0.57 | |
| Sales general and administrative to revenue | 0.18 | 0.17 | 0.16 | 0.16 | 0.05 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 4.64 | -0.05 | -0.38 | -0.12 | |
| Capex to revenue | 0 | 2.94 | -0.03 | -0.26 | -0.07 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.76 | 1.49 | 1.56 | 1.06 | 1.75 | |
| ROIC | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 | |
| Return on tangible assets | 0.07 | 0.07 | 0.06 | 0.03 | 0.07 | |
| Graham Net | 0.08 | -0.2 | -0.23 | -0.25 | -0.43 | |
| Working capital | 45.26M | 4.94M | 8.12M | 135K | -3.43M | |
| Tangible asset value | 340.68M | 349.52M | 394.24M | 445.92M | 478.11M | |
| Net current asset value | 20.03M | -72.06M | -105.43M | -126.53M | -189.18M | |
| Invested capital | 0.07 | 0.22 | 0.29 | 0.31 | 0.38 | |
| Average receivables | 2.78M | 7.99M | 27.12M | 38.24M | 20.17M | |
| Average payables | 1.29M | 1.25M | 2.1M | 3.14M | 3.43M | |
| Average inventory | 0 | -3.92M | -3.92M | 0 | 0 | |
| Days sales outstanding | 1.04 | 186.23 | 379.09 | 324.42 | 15.67 | |
| Days payables outstanding | 140.42 | 124.46 | 239.67 | 236.2 | 220.44 | |
| Days of inventory on hand | 0 | -729.91 | 0 | 0 | 0 | |
| Receivables turnover | 351.19 | 1.96 | 0.96 | 1.13 | 23.3 | |
| Payables turnover | 2.6 | 2.93 | 1.52 | 1.55 | 1.66 | |
| Inventory turnover | 0 | -0.5 | 0 | 0 | 0 | |
| ROE | 0.08 | 0.08 | 0.08 | 0.04 | 0.1 | |
| Capex per share | 0 | 0.29 | 0 | -0.03 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.05 | 0.05 | 0.06 | 0.06 | 0.07 | |
| Net income per share | 0.05 | 0.07 | -0.03 | 0.07 | 0.05 | |
| Operating cash flow per share | 0.04 | 0.03 | 0.04 | 0.04 | 0.03 | |
| Free cash flow per share | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | |
| Cash per share | 0.04 | 0.06 | 0.06 | 0.05 | 0.02 | |
| Book value per share | 1.12 | 1.19 | 1.1 | 1.14 | 1.15 | |
| Tangible book value per share | 1.12 | 1.19 | 1.1 | 1.14 | 1.15 | |
| Share holders equity per share | 1.12 | 1.19 | 1.1 | 1.14 | 1.15 | |
| Interest debt per share | 0.33 | 0.36 | 0.35 | 0.46 | 0.45 | |
| Market cap | 418.12M | 438.99M | 425M | 372.55M | 369.62M | |
| Enterprise value | 515.77M | 551.16M | 539.67M | 535.83M | 540.16M | |
| P/E ratio | 5.99 | 4.02 | -10.21 | 3.38 | 4.35 | |
| Price to sales ratio | 22.21 | 21.91 | 18.55 | 15.86 | 13.67 | |
| POCF ratio | 33.65 | 33.46 | 25.98 | 25.45 | 27.53 | |
| PFCF ratio | 36.75 | 52.15 | 43.09 | 27.04 | 33.88 | |
| P/B Ratio | 1.06 | 0.98 | 0.95 | 0.79 | 0.77 | |
| PTB ratio | 1.06 | 0.98 | 0.95 | 0.79 | 0.77 | |
| EV to sales | 27.4 | 27.51 | 23.55 | 22.82 | 19.97 | |
| Enterprise value over EBITDA | 32.98 | 32.43 | 32.85 | 28.15 | 23.7 | |
| EV to operating cash flow | 41.51 | 42.01 | 32.99 | 36.61 | 40.23 | |
| EV to free cash flow | 45.34 | 65.47 | 54.71 | 38.88 | 49.51 | |
| Earnings yield | 0.04 | 0.06 | -0.02 | 0.07 | 0.06 | |
| Free cash flow yield | 0.03 | 0.02 | 0.02 | 0.04 | 0.03 | |
| Debt to equity | 0.29 | 0.3 | 0.31 | 0.39 | 0.38 | |
| Debt to assets | 0.22 | 0.23 | 0.23 | 0.28 | 0.27 | |
| Net debt to EBITDA | 6.24 | 6.6 | 6.98 | 8.58 | 7.48 | |
| Current ratio | 2.21 | 2.37 | 1.01 | 2.54 | 0 | |
| Interest coverage | 9 | 7.81 | 5.08 | 4.3 | 3.21 | |
| Income quality | 0.71 | 0.48 | -1.57 | 0.53 | 0.63 | |
| Dividend Yield | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | |
| Payout ratio | 0.64 | 0.46 | -1.27 | 0.5 | 0.66 | |
| Sales general and administrative to revenue | 0.16 | 0.16 | 0.17 | 0.16 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.08 | -0.36 | -0.4 | -0.06 | -0.19 | |
| Capex to revenue | -0.06 | -0.23 | -0.28 | -0.04 | -0.09 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.12 | 1.4 | 0.8 | 1.31 | 1.15 | |
| ROIC | 0 | 0.01 | 0.08 | 0.01 | 0.03 | |
| Return on tangible assets | 0.03 | 0.05 | -0.02 | 0.04 | 0.03 | |
| Graham Net | -0.22 | -0.2 | -0.24 | -0.36 | -0.43 | |
| Working capital | 8.12M | 13.79M | 135K | 14.79M | -3.43M | |
| Tangible asset value | 394.24M | 448.13M | 445.92M | 470.89M | 478.11M | |
| Net current asset value | -105.43M | -123M | -126.53M | -172.94M | -189.18M | |
| Invested capital | 0.29 | 0.3 | 0.31 | 0.39 | 0.38 | |
| Average receivables | 30M | 52.36M | 52.29M | 37.67M | 19.66M | |
| Average payables | 3.49M | 6.47M | 6.75M | 6.52M | 6.52M | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 183.2 | 298.33 | 149.95 | 142.41 | 7.22 | |
| Days payables outstanding | 989.65 | 2.34K | 970.98 | 2.06K | 686.2 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0.49 | 0.3 | 0.6 | 0.63 | 12.47 | |
| Payables turnover | 0.09 | 0.04 | 0.09 | 0.04 | 0.13 | |
| Inventory turnover | 0 | 0 | 0 | 113011.33B | 0 | |
| ROE | 0.04 | 0.06 | -0.02 | 0.06 | 0.04 | |
| Capex per share | 0 | -0.01 | -0.02 | 0 | -0.01 |
IHR.L Frequently Asked Questions
What is Impact Healthcare REIT PLC stock symbol ?
Impact Healthcare REIT PLC is a GB stock and trading under the symbol IHR.L
What is Impact Healthcare REIT PLC stock quote today ?
Impact Healthcare REIT PLC stock price is $82.9 today.
Is Impact Healthcare REIT PLC stock public?
Yes, Impact Healthcare REIT PLC is a publicly traded company.
Company Profile
- Volume Average 633.67K
- Market Capitalization 348.9M
- CEO Mr. Mahesh Shivabhai Patel A.C.A.
- Headquarters London,GB
- IPO Date 2017-03-07
-
Website
https://www.impactreit.uk 
Impact Healthcare REIT Plc is a real estate investment trust externally managed by Carne Global AIFM Solutions. The firm invests in the real estate markets of United Kingdom. It primarily acquires, owns, leases, renovates, extends and redevelops high quality healthcare real estate assets. Impact Healthcare REIT Plc was formed on 7 November 2016 and is based in London, United Kingdom.
